flutamide and arachidonic acid

flutamide has been researched along with arachidonic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alanen, KA; Fey, V; Gupta, S; Iljin, K; Kallioniemi, O; Ketola, K; Kohonen, P; Mirtti, T; Mpindi, JP; Perälä, M; Schalken, J; Smit, F; Vainio, P; Verhaegh, G	1

Other Studies

1 other study(ies) available for flutamide and arachidonic acid

Article	Year
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. The American journal of pathology, 2011, Volume: 178, Issue:2 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Aged, 80 and over; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Epoxide Hydrolases; Flutamide; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Oxidative Stress; Phospholipase A2 Inhibitors; Phospholipases A2; Prostatic Neoplasms; Receptors, Androgen; Reproducibility of Results; RNA, Messenger; Signal Transduction	2011

Article

Year

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

The American journal of pathology, 2011, Volume: 178, Issue:2

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Aged, 80 and over; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Epoxide Hydrolases; Flutamide; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Oxidative Stress; Phospholipase A2 Inhibitors; Phospholipases A2; Prostatic Neoplasms; Receptors, Androgen; Reproducibility of Results; RNA, Messenger; Signal Transduction

2011